Readmission in the Case of Patients With Heart Failure
PRADO-IC
1 other identifier
observational
100
1 country
1
Brief Summary
Heart failure (HF) is a serious chronic disease with frequent readmissions, some of which can be prevented by early action. The management of HF is complex: long, often difficult and costly. In France, nearly one million people suffer from HF and 120,000 new cases are diagnosed every year. With the aging population, this number will continue to evolve and become a real public health problem. Within 10 to 20 years ahead, WHO projects that heart failure in either the 3 most common diseases in industrialized countries. Investigators goals are to make an inventory of PRADO-IC project in terms of its effectiveness on readmission of patients with heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 12, 2016
CompletedFirst Posted
Study publicly available on registry
June 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJune 16, 2017
June 1, 2017
1.4 years
April 12, 2016
June 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The cost of re-hospitalization in the case of patients with heart failure reach
during 2015
Eligibility Criteria
Patients with heart failure.
You may qualify if:
- Patient aged 18 or over
- Patient readmitted for heart failure
You may not qualify if:
- Population whose age is less than 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Médecine Interne, diabète et maladies métaboliques - Médicale B
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Emmanuel ANDRES, MD, PhD
University Hospital, Strasbourg, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2016
First Posted
June 21, 2016
Study Start
April 1, 2016
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
June 16, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share